New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies

L Niu, L Liu, S Yang, J Ren, PBS Lai… - Biochimica et Biophysica …, 2017 - Elsevier
It is disappointing that only a few patients with hepatocellular carcinoma (HCC) obtain a
significant survival benefit from the sorafenib treatment, which is currently regarded as a first …
被引用次数：200 相关文章

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.

L Niu, L Liu, S Yang, J Ren, PBS Lai… - … et Biophysica acta …, 2017 - europepmc.org
It is disappointing that only a few patients with hepatocellular carcinoma (HCC) obtain a
significant survival benefit from the sorafenib treatment, which is currently regarded as a first …

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies

L Niu, L Liu, S Yang, J Ren… - … et biophysica acta …, 2017 - pubmed.ncbi.nlm.nih.gov
It is disappointing that only a few patients with hepatocellular carcinoma (HCC) obtain a
significant survival benefit from the sorafenib treatment, which is currently regarded as a first …